Project Grant K24AG084923
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $159,492 to Weill Medical College of Cornell University to support research focused on identifying and characterizing clonal expansions in aging and aging-related diseases. The key products/services to be delivered under this award include: Developing tools to enable the identification of candidate somatic variants at scale from publicly available data using machine learning approaches. Applying...
- This federal Project Grant award, valued at $1,552,000.00 and provided by the National Institute on Aging (CFDA 93.866 - Aging Research), supports a research study examining the relationship between markers of vascular and immune dysfunction, such as platelet aggregation and neutrophil levels, and their association with dementia risk and increased Alzheimer's disease (AD) biomarkers. The study, conducted by New York University School of Medicine, aims to integrate biofluid biomarker data with...
- This federal Project Grant award for $366,648.00 was provided by the National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), to New York University (NYU). The funding supports the development of statistical methods for improving estimation and prediction models related to Alzheimer's disease (AD) progression, leveraging data from longitudinal cohort studies. Specifically, the project aims to address challenges posed by complex truncation and censoring...
- This federal Project Grant award of $641,856 from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research to determine the effects of reduced nursing home capacity on older adults, their caregivers, and post-acute/long-term care access. The project, which runs from September 1, 2025 to May 31, 2030, will conduct rigorous quantitative analyses to assess the implications of nursing home capacity declines, which have accelerated due to the COVID-19 pandemic. The...
- This federal Project Grant award, provided by the National Institute on Aging (CFDA 93.866 Aging Research), aims to study the impact of frailty on disease relapse and therapy intensity in older adults with acute myeloid leukemia (AML). The $243,000 award to the University of Pennsylvania will support research to identify biomarkers and develop treatment selection strategies for this population. The project, running from September 2025 to May 2030, seeks to address the significant disparity in...
- The National Institute on Aging (NIA) awarded a $713,723.32 Project Grant under the Aging Research Federal Grant Program (CFDA 93.866) to the Albert Einstein College of Medicine in Bronx, NY. The award, effective from February 1, 2025 to January 31, 2028, will support research on the influence of neighborhood characteristics, both objective and subjective, as well as GPS-based personal activity space measures, on cognitive decline, Alzheimer's disease and related dementias (ADRD), and...
- This $1,306,862 Project Grant awarded by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) will fund research on the relationship between real estate investment trust (REIT) investments in nursing homes and the quality of end-of-life care for residents with Alzheimer's disease and related dementias. The project, led by Weill Medical College of Cornell University, will construct a nationally representative database of nursing home residents with...
- This $740,075 Project Grant was awarded by the National Institute on Aging (CFDA 93.866 Aging Research) to Weill Medical College of Cornell University on September 15, 2025. The grant supports research to investigate the role of mitochondrial-derived reactive oxygen species (ROS) from Complex III (CIII) in influencing nuclear processes and Alzheimer's disease (AD) pathogenesis. Key research approaches include live-cell redox imaging, genetic manipulations, molecular profiling, and preclinical...
- The National Institute on Aging (NIA) awarded a $596,258 Project Grant (CFDA 93.866 - Aging Research) to Weill Medical College of Cornell University to characterize and predict patient trajectories after live discharge from hospice among older adults with Alzheimer's disease and related dementias (ADRD). The project aims to apply longitudinal clustering methods to Medicare claims and encounter data to identify patient subgroups with heterogeneous trajectories after hospice live discharge,...
- This Project Grant award of $1,631,690.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) to Beth Israel Deaconess Medical Center, Inc. (Bidmc) supports a research project titled "Proteomic Signatures of Delirium and Long-Term Cognitive Decline in Older Cardiac Surgical Patients." The project aims to use state-of-the-art proteomics analysis to derive and validate a delirium protein signature for cardiac surgery patients, leveraging plasma samples from an ongoing...
This Project Grant award of $212,770 from the National Institute on Aging (CFDA 93.866 Aging Research) aims to improve the identification, intervention, and prevention of elder mistreatment among individuals living with Alzheimer's disease and related dementias (ADRD). The key products and services to be delivered include: The award was granted to the Weill Medical College of Cornell University, a leading academic medical institution, and the project period runs from August 2025 through April 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $212.8k | 8/13/25 |